Floatz logo

Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer

Biliary Tract Neoplasm

National Cancer Institute (NCI)monoclonal_antibodyPhase 2Dormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Biliary Tract Neoplasm cohort.

Asset / SponsorPhaseRating
Durvalumab
National Cancer Institute (NCI)
Phase 2BB
Docetaxel
ARCAGY/ GINECO GROUP
Phase 2B
Fulvestrant
Seagen, a wholly owned subsidiary of Pfizer
Phase 2CCC
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Shr-1805 ?1-Chain), Complex With Human-Mus Musculus Monoclonal Shr-1805 ?-Chain, Dimer, Thioether With N-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]Glycylglycyl-L-Phenylalanyl-N-[[(1R)-1-Cyclopropyl-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-2-Oxoethoxy]Methyl]Glycinamide
Haihua Yuan
Phase 2CCC
Tucatinib
Seagen, a wholly owned subsidiary of Pfizer
Phase 2CCC

View all 12 →

Same molecule, other indications

Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer is also rated in:

malignant pancreatic neoplasmActive
BB
Indicative · Phase 2
68 / 100
View asset →
pancreatic ductal adenocarcinomaActive
BB
Indicative · Phase 2
66 / 100
View asset →
Her2-receptor negative breast cancerDormant
BB
Indicative · Phase 2
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →